STOCK TITAN
  1. Home
  2. News
  3. BSGM

BioSig Technologies, Inc. - $BSGM STOCK NEWS

Welcome to our dedicated page for BioSig Technologies news (Ticker: $BSGM), a resource for investors and traders seeking the latest updates and insights on BioSig Technologies stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BioSig Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BioSig Technologies's position in the market.

News
BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP
Rhea-AI Summary
BioSig Technologies, Inc. (NASDAQ: BSGM) appoints Frederick Hrkac, a 32-year medical device industry veteran, as Executive Vice President. His extensive experience includes leading Johnson & Johnson's cardiology/electrophysiology business to a $500M revenue and facilitating a $1B sale of a medical device company in 2018.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.87%
Tags
management
-
News
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care
Rhea-AI Summary
BioSig Technologies, Inc. announced that Mayo Clinic-Phoenix has upgraded to the PURE EP™ Platform's subscription model to access the latest advancements in cardiac arrhythmia identification. The new software features include Automatic Tachycardia Characterization (ATC) and Near-Field Tracking (NFT) to assist electrophysiologists in ablation procedures. Mayo Clinic-Phoenix is ranked as the number one hospital in Arizona and is now part of the PURE EP™ subscriber community, along with Cleveland Clinic.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
none
-
News
BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio Covering Digital Signal Processing Technology and AI
Rhea-AI Summary
BioSig Technologies has been awarded five new utility patents by the U.S. Patent and Trademark Office for its PURE EP digital signal processing technology. The patents cover various aspects of signal visualization and processing in cardiac signals. BioSig now has a total of 35 issued and allowed utility patents, 30 issued design patents, and 23 pending utility patent applications for the PURE EP platform.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
31.9%
Tags
AI
News
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
Rhea-AI Summary
BioSig Technologies provides update on AI medical device platform development
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.7%
Tags
AI
-
News
BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations
Rhea-AI Summary
Cleveland Clinic signs on as first subscriber to BioSig's PURE EP Platform
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.19%
Tags
none
-
News
BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient Cases
Rhea-AI Summary
BioSig Technologies releases new software features for the PURE EP™ Platform, enhancing capabilities for electrophysiologists to visualize heart patterns. The features include Near-Field Tracking (NFT) and Automatic Tachycardia Characterization (ATC). The software upgrade builds on existing features like PURE ZONE™ and High Frequency Algorithm (HFA). Research shows a 66% reduction in procedure time with PURE EP™, potentially leading to cost savings of $418.10 per procedure and over $30 million annually for healthcare. The update also allows for additional reimbursement options.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.76%
Tags
none
News
BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications
Rhea-AI Summary
BioSig Technologies, Inc. has completed a seed funding round, raising $2.2 million for its subsidiary, BioSig AI Sciences, Inc. The subsidiary aims to advance the research and development of an artificial intelligence medical device platform. The collaboration between BioSig and Reified Labs has resulted in multiple patent applications and a research publication on AI-enhanced electrocardiogram lead placement mapping. The market for artificial intelligence in healthcare is projected to reach $272.9 billion by 2030, with a CAGR of 51.9%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.98%
Tags
AI
-
News
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
Rhea-AI Summary
BioSig Technologies' subsidiary, BioSig AI Sciences, has been selected to join NVIDIA Inception, a program that supports companies revolutionizing industries with AI advancements. This partnership will provide engineering guidance, technical training, and exposure to the NVIDIA investment community. BioSig plans to leverage NVIDIA's resources to advance its AI medical device platform and identify transformative applications in healthcare.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.92%
Tags
partnership AI
-
News
BioSig Joins Webull Corporate Connect
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.5%
Tags
none
News
BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.03%
Tags
none
Stock BSGM logo
BioSig Technologies, Inc.

Nasdaq:BSGM

BSGM Rankings

#5293 Ranked by Market Cap
#2437 Ranked by Stock Gains
N/A Ranked by Dividends

BSGM Stock Data

14.22M
6.29M
22.56%
11.41%
7.44%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
WESTPORT

About BSGM

biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.